UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo
|
2018-11-07 16:06
라인
Two Koreas discuss jointly blocking infectious diseases
Health authorities from South and North Korea met on Wednesday, 11 years af...
by Kwak Sung-sun
|
2018-11-07 15:00
라인
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon
|
2018-11-07 14:58
라인
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo
|
2018-11-07 12:26
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun
|
2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon
|
2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun
|
2018-11-06 15:41
라인
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo
|
2018-11-06 11:09
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon
|
2018-11-06 11:06
라인
Samsung BioLogics to complete Biogen’s call option
Samsung BioLogics posted Tuesday that the transfer of assets related to Sam...
by Lee Han-soo
|
2018-11-06 10:45
라인
SMC completes 20 cases of artificial heart transplant
Samsung Medical Center said Monday that it has become the first local hospi...
by Lee Han-soo
|
2018-11-06 10:44
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun
|
2018-11-05 16:32
라인
GTG Wellness to export body composition analyzer to Australia
GTG Wellness CEO Kim Tae-hyun (left) and Evolt IOH CEO Ed Zouroudis hold up...
by Lee Han-soo
|
2018-11-05 16:32
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon
|
2018-11-05 15:26
라인
Does Korean traditional cold remedy work?
With the temperature dropping down, the number of Koreans coming down with ...
by Lee Han-soo
|
2018-11-05 15:25
라인
Korea to promote digital healthcare firms in Southeast Asia
The Ministry of Health and Welfare will hold an event in Hanoi and Jakarta ...
by Kwak Sung-sun
|
2018-11-05 14:29
라인
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo
|
2018-11-05 13:31
라인
‘Different medical training may impede inter-Korean healthcare cooperation’
The different medical training system for physicians and nurses between two...
by Kwak Sung-sun
|
2018-11-05 13:30
라인
Standigm launches AI-driven lead optimization service for drug discovery
Standigm, a company using artificial intelligence (AI) technology for drug ...
by Lee Han-soo
|
2018-11-05 11:16
라인
Lilly Korea’s rheumatoid arthritis treatment wins insurance coverage
Lilly Korea said Thursday that it has gained reimbursement for its rheumato...
by Lee Han-soo
|
2018-11-02 17:52
-
이전
171
172
173
174
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top